Corporate Overview
History:
Founded in 2016; successfully uplisted to Nasdaq in December 2018; Headquarters in Freehold, New Jersey; approx. 60 FTEs (including subsidiaries)
Core Technology Platforms:
- Cellular Immunotherapies
- Including Chimeric Antigen Receptor (CAR)-T, RNA-based FLASH-CARTM and AVA-TrapTM
- Precision Diagnostics / Clinical Laboratory Services